Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

George W Lemaitre

CEO, Chair at Lemaitre Vascular Inc (LMAT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $27.1M

Reported trades

Filed Stock Type Shares Price Value Since
May 11SEC LMATLemaitre Vascular Inc Sell 18,6001,457,900 held (−1%) $107.64 $2.0M -25.0%
May 11SEC LMATLemaitre Vascular Inc Sell 27,8811,430,019 held (−2%) $108.69 $3.0M -25.8%
Mar 2SEC LMATLemaitre Vascular Inc Sell Plan 150,0001,532,304 held (−9%) $106.76 $16.0M -24.4%
Mar 2SEC LMATLemaitre Vascular Inc Sell Plan 55,9301,476,500 held (−4%) $107.81 $6.0M -25.2%
  • Sell

    CEO, Chair George W Lemaitre sold $16.0M of LMAT at $106.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair George W Lemaitre sold $6.0M of LMAT at $107.81 — pre-scheduled 10b5-1 plan sale.